The 34th Annual Meeting of the Society for Medical Decision Making: Concurrent Oral Sessions

Category Reference for Presentations
AHEApplied Health Economics HTAHealth Technology Assessment
DECDecision Psychology and Shared Decision Making INFINFORMS
HSPHealth Services, and Policy Research METQuantitative Methods and Theoretical Developments
* Candidate for the Lee B. Lusted Student Prize Competition

Wednesday, October 17, 2012, Day One
1:30 - 5:45 PM
Attendees are invited to move from room-to-room
Room
Session Title INF. INFORMS / SMDM JOINT PRESENTATIONS Click to view session
1:30 - 5:40 INF-1 (INF) INFORMS/SMDM APPLICATIONS JOINT CLUSTER INF-1 (INF) INFORMS/SMDM APPLICATIONS JOINT CLUSTER
Thursday, October 18, 2012, Day Two
9:00 - 10:00 AM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B
Session Title KEY. KEYNOTE PRESENTATION - NIRAV R. SHAH, MD, MPH, NEW YORK STATE HEALTH DEPARTMENT Click to view session
9:00 - 10:00 KEY-1 (HSP) BUILDING A HEALTHCARE ECOSYSTEM KEY-1 (HSP) BUILDING A HEALTHCARE ECOSYSTEM
10:30 - 12:00 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B Regency Ballroom C
Session Title TRA1. TOP-RANKED ABSTRACTS, CONCURRENT PRESENTATION 1 Click to view session TRA2. TOP-RANKED ABSTRACTS, CONCURRENT PRESENTATION 2 Click to view session
10:30 - 10:48 TRA1-1 (DEC, INF) IMPROVING PHYSICIAN PRESCRIBING DECISIONS.. TRA1-1 (DEC, INF) IMPROVING PHYSICIAN PRESCRIBING DECISIONS THROUGH USER INTERFACE REDESIGN TRA2-1 (INF, HSP) REAL-TIME PREDICTIVE MODELING TO STRATIFY RISK.. TRA2-1 (INF, HSP) REAL-TIME PREDICTIVE MODELING TO STRATIFY RISK FOR ALL ADULT INPATIENTS TO REDUCE HOSPITAL READMISSIONS
10:48 - 11:06 TRA1-2 (DEC) WHAT'S IN A NAME? THE INFLUENCE OF A DISEASE.. TRA1-2 (DEC) WHAT'S IN A NAME? THE INFLUENCE OF A DISEASE LABEL ON A PARENT'S DECISION TO MEDICATE A FUSSY BABY TRA2-2* (INF, AHE) ESTIMATING THE COST-EFFECTIVENESS OF XPERT.. TRA2-2* (INF, AHE) ESTIMATING THE COST-EFFECTIVENESS OF XPERT MTB/RIF: APPLYING A BAYESIAN CALIBRATION APPROACH TO A DYNAMIC TB-HIV EPIDEMIC MODEL
11:06 - 11:24 TRA1-3 (DEC) THE EFFECT OF EMOTION AND PHYSICIAN COMMUNICAT.. TRA1-3 (DEC) THE EFFECT OF EMOTION AND PHYSICIAN COMMUNICATION BEHAVIORS ON SURROGATES' LIFE-SUSTAINING TREATMENT DECISIONS: A RANDOMIZED TRIAL TRA2-3* (INF, AHE) THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE.. TRA2-3* (INF, AHE) THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE ACCURACY ON THE COST-EFFECTIVENESS HELICOPTER SCENE TRANSPORT FOR TRAUMA
11:24 - 11:42 TRA1-4 (INF, DEC) MODELING PERSONALIZED RANK ORDER OF PREVENTIVE.. TRA1-4 (INF, DEC) MODELING PERSONALIZED RANK ORDER OF PREVENTIVE CARE GUIDELINES TRA2-4* (MET) USE OF BAYESIAN BIVARIATE RANDOM-EFFECTS.. TRA2-4* (MET) USE OF BAYESIAN BIVARIATE RANDOM-EFFECTS META-ANALYSIS TO EXPLORE UNCERTAINTY IN THE TREATMENT EFFECT OF VITAMIN K ON BONE MINERAL DENSITY AND FRACTURES
11:42 - 12:00 TRA1-5 (HSP) AN INFUENZA VACCINATION POLICY BASED ON A.. TRA1-5 (HSP) AN INFUENZA VACCINATION POLICY BASED ON A PREVIOUS YEAR'S ILLNESS TRA2-5 (INF, MET) CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYI.. TRA2-5 (INF, MET) CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYING, MODIFIABLE RISK FACTORS: THE EXAMPLE OF SMOKING INITIATION AND QUITTING IN INDIA
12:45 - 1:30 PM
Attendees are invited to move from room-to-room
Room Sundance
Session Title RFF1. REPORTS FROM THE FIELD 1: Click to view session
12:45 - 1:00 RFF1-1 (HTA) REPORTS FROM THE FIELD, ONC HITECH - VISIONS.. RFF1-1 (HTA) REPORTS FROM THE FIELD, ONC HITECH - VISIONS FOR THE FUTURE OF HEALTH INFORMATION
1:30 - 3:00 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B Regency Ballroom C Regency Ballroom D
Session Title A. LUSTED FINALIST ABSTRACTS: DECISION PSYCHOLOGY AND SHARED DECISION MAKING Click to view session B. GUIDELINES AND MEASUREMENT OF HEALTH DECISION MAKING Click to view session C. METHODOLOGICAL ADVANCES IN HEALTH DECISION MAKING Click to view session
1:30 - 1:45 A-1* (DEC) DEVELOPMENT OF AN INTERNET-BASED PATIENTS'.. A-1* (DEC) DEVELOPMENT OF AN INTERNET-BASED PATIENTS' DECISION AID FOR SURGICAL VERSUS NONSURGICAL MANAGEMENT OF KNEE OSTEOARTHRITIS B-1 (INF, HSP) OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR.. B-1 (INF, HSP) OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR CLINICAL MANAGEMENT OF PULMONARY NODULES USING A LUNG CANCER MODEL C-1 (INF, MET) DON'T USE A LOT WHERE A LITTLE WILL DO: A.. C-1 (INF, MET) DON'T USE A LOT WHERE A LITTLE WILL DO: A MINIMAL INFORMATION DECISION-ANALYTIC APPROACH TO EARLY HTA OF DIAGNOSTIC TESTS
1:45 - 2:00 A-2* (DEC) WOMEN'S RESPONSES TO INFORMATION ABOUT.. A-2* (DEC) WOMEN'S RESPONSES TO INFORMATION ABOUT OVERDIAGNOSIS IN MAMMOGRAPHY SCREENING B-2 (INF, AHE) EXAMINING PARAMETERS THAT IMPACT INCREMENTAL.. B-2 (INF, AHE) EXAMINING PARAMETERS THAT IMPACT INCREMENTAL COST-EFFECTIVENESS RATIOS C-2 (MET) MULTIPLE IMPUTATION METHODS FOR HANDLING.. C-2 (MET) MULTIPLE IMPUTATION METHODS FOR HANDLING MISSING DATA IN COST-EFFECTIVENESS ANALYSES: AN APPLICATION TO CLUSTER RANDOMISED TRIALS
2:00 - 2:15 A-3* (DEC) RADICAL SURGERY VERSUS RADICAL RADIATION FOR.. A-3* (DEC) RADICAL SURGERY VERSUS RADICAL RADIATION FOR ADVANCED BLADDER CANCER: A DECISION ANALYSIS B-3* (AHE) ASK A DIFFERENT QUESTION, GET A DIFFERENT.. B-3* (AHE) ASK A DIFFERENT QUESTION, GET A DIFFERENT ANSWER: ISOLATING THE INFLUENCE OF VARIATION IN THE DESCRIPTIVE SYSTEMS OF THE EQ-5D AND SF-6D C-3 (MET) JOINTNESS BOX: A NOVEL METHOD TO CONTEMPLATE.. C-3 (MET) JOINTNESS BOX: A NOVEL METHOD TO CONTEMPLATE VALUE OF INDIVIDUALIZED CARE FROM TRADITIONAL TRIAL DATA
2:15 - 2:30 A-4* (INF, DEC) THE EFFECT OF IMPLICIT VERSUS EXPLICIT.. A-4* (INF, DEC) THE EFFECT OF IMPLICIT VERSUS EXPLICIT DELIBERATIVE GUIDANCE AND THE ROLE OF PATIENTS' DELIBERATIVE STYLES IN INTERACTIVE ONLINE PATIENTS' DECISION AIDS B-4 (HSP) REFERRAL BIAS IN THE DIAGNOSTIC PERFORMANCE OF.. B-4 (HSP) REFERRAL BIAS IN THE DIAGNOSTIC PERFORMANCE OF EXERCISE TESTING WITH IMAGING FOR CORONARY ARTERY DISEASE C-4 (MET) NEW METHODS FOR INTEGRATING PATIENT PREFERENCE.. C-4 (MET) NEW METHODS FOR INTEGRATING PATIENT PREFERENCES WITH CLINICAL EVIDENCE
2:30 - 2:45 A-5* (DEC) PHYSICIAN INNUMERACY IS ASSOCIATED WITH MORE.. A-5* (DEC) PHYSICIAN INNUMERACY IS ASSOCIATED WITH MORE ENTHUSIASM FOR CANCER SCREENING B-5 (DEC) PSYCHOMETRIC PROPERTIES OF A NEW MEDICAL RISK.. B-5 (DEC) PSYCHOMETRIC PROPERTIES OF A NEW MEDICAL RISK SUBSCALE FOR DOSPERT C-5 (MET) COMBINING RANDOM FORESTS AND BAYESIAN GLM FOR.. C-5 (MET) COMBINING RANDOM FORESTS AND BAYESIAN GLM FOR ESTIMATION OF HETEROGENEOUS TREATMENT EFFECTS
2:45 - 3:00 A-6* (HSP) INTEGRATING PATIENT PREFERENCES AND CLINICAL.. A-6* (HSP) INTEGRATING PATIENT PREFERENCES AND CLINICAL TRIAL DATA IN A BAYESIAN MODEL FOR QUANTITATIVE RISK-BENEFIT ASSESSMENT B-6 (DEC) A RANDOMIZED CONTROLLED TRIAL OF TWO.. B-6 (DEC) A RANDOMIZED CONTROLLED TRIAL OF TWO PRINCIPLES OF DIAGNOSTIC SUPPORT C-6 (INF, MET) PROBABILISTIC SENSITIVITY ANALYSIS WITH.. C-6 (INF, MET) PROBABILISTIC SENSITIVITY ANALYSIS WITH EFFICIENT SAMPLING TECHNIQUE IN PATIENT-LEVEL SIMULATION MODELS
3:15 - 4:30 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B
Session Title SYM1. INVITED SPEAKER SYMPOSIUM: HEALTH INFORMATION TECHNOLOGY CHALLENGES IN AGING PATIENTS Click to view session
3:15 - 3:16 SYM1-1 (AHE) HEALTH INFORMATION TECHNOLOGY CHALLENGES IN.. SYM1-1 (AHE) HEALTH INFORMATION TECHNOLOGY CHALLENGES IN AGING PATIENTS
3:16 - 3:41 SYM1-2 (AHE) INFORMATICS CHALLENGES IN THE MANAGEMENT OF.. SYM1-2 (AHE) INFORMATICS CHALLENGES IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MORBIDITIES
3:41 - 4:06 SYM1-3 (AHE) INTEGRATION OF GENOMICS AND CLINICAL DECISION.. SYM1-3 (AHE) INTEGRATION OF GENOMICS AND CLINICAL DECISION SUPPORT FOR AGING PATIENTS
4:06 - 4:30 SYM1-4 (AHE) SUMMARY AND DISCUSSION / QUESTIONS SYM1-4 (AHE) SUMMARY AND DISCUSSION / QUESTIONS
4:30 - 6:00 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B Regency Ballroom C Regency Ballroom D
Session Title D. SHARED DECISION MAKING AND DECISION SUPPORT INTERVENTIONS Click to view session E. LUSTED FINALIST ABSTRACTS: APPLIED HEALTH ECONOMICS Click to view session F. RISK AND COST EFFECTIVENESS MODELING Click to view session
4:30 - 4:45 D-1 (DEC) TESTING THE ADDED VALUE OF DECISION AID.. D-1 (DEC) TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS E-1* (INF, AHE) OPTIMAL INFORMATION ACQUISITION POLICY IN.. E-1* (INF, AHE) OPTIMAL INFORMATION ACQUISITION POLICY IN DYNAMIC HEALTHCARE POLICY: APPLICATION TO HCV SCREENING F-1 (AHE) COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE.. F-1 (AHE) COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN THE IMMUNOCOMPROMISED
4:45 - 5:00 D-2 (DEC) AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN.. D-2 (DEC) AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK E-2* (AHE) COST EFFECTIVENESS OF DIFFERENT INTERVENTIONS.. E-2* (AHE) COST EFFECTIVENESS OF DIFFERENT INTERVENTIONS FOR TREATING PATIENTS WITH NEWLY-DIAGNOSED DIABETIC MACULAR EDEMA F-2 (INF, HSP) SCREEN MORE OR SCREEN MORE OFTEN? USING.. F-2 (INF, HSP) SCREEN MORE OR SCREEN MORE OFTEN? USING MATHEMATICAL MODELS TO INFORM SYPHILIS CONTROL STRATEGIES
5:00 - 5:15 D-3 (DEC) CAN A DASHBOARD BE USED TO MONITOR INFORMED.. D-3 (DEC) CAN A DASHBOARD BE USED TO MONITOR INFORMED PATIENT CHOICE? E-3* (AHE) THE COST-EFFECTIVENESS OF MRI IN THE DIAGNOSIS.. E-3* (AHE) THE COST-EFFECTIVENESS OF MRI IN THE DIAGNOSIS OF ACUTE APPENDICITIS DURING PREGNANCY: A GUIDE FOR SURGICAL DECISION-MAKING F-3* (MET) COMBINING REGRESSION ANALYSES AND MARKOV.. F-3* (MET) COMBINING REGRESSION ANALYSES AND MARKOV MODELS TO INFER AGE-SPECIFIC MORTALITY RATES BY HEPATITIS C INFECTION AND RISK FACTOR STATUS
5:15 - 5:30 D-4 (DEC) USING INFORMATION TECHNOLOGY TO FACILITATE.. D-4 (DEC) USING INFORMATION TECHNOLOGY TO FACILITATE SHARED DECISION MAKING FOR PATIENTS ELIGIBLE FOR CANCER SCREENING E-4* (AHE) COST EFFECTIVENESS OF STEREOTACTIC BODY.. E-4* (AHE) COST EFFECTIVENESS OF STEREOTACTIC BODY RADIATION THERAPY FOR MEDICALLY OPERABLE STAGE I NON–SMALL CELL LUNG CANCER F-4 (AHE) COST-EFFECTIVENESS OF MORE FREQUENT HIV.. F-4 (AHE) COST-EFFECTIVENESS OF MORE FREQUENT HIV SCREENING OF POPULATIONS AT RISK
5:30 - 5:45 D-5 (DEC) NOVEL METHODS TO OVERCOME HEALTH LITERACY.. D-5 (DEC) NOVEL METHODS TO OVERCOME HEALTH LITERACY BARRIERS TO SHARED DECISION MAKING IN PROSTATE CANCER AMONG LOW-INCOME AFRICAN AMERICAN MEN E-5* (AHE) A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR.. E-5* (AHE) A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR PREVENTING CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE F-5 (INF, MET) AN ALGORITHM FOR STOCHASTICALLY SIMULATING THE.. F-5 (INF, MET) AN ALGORITHM FOR STOCHASTICALLY SIMULATING THE CAUSE OF DEATH IN HEART FAILURE PATIENTS
5:45 - 6:00 D-6 (DEC) DOES HEALTH COACHING AFFECT THE DECISION.. D-6 (DEC) DOES HEALTH COACHING AFFECT THE DECISION PROCESS FOR PATIENTS CHOOSING A SPINAL STENOSIS TREATMENT? E-6* (AHE) COST-EFFECTIVENESS OF INCREASING CERVICAL.. E-6* (AHE) COST-EFFECTIVENESS OF INCREASING CERVICAL CANCER SCREENING COVERAGE AND EFFICIENCY IN LEBANON F-6 (MET) USING SIMULATED DATA TO VALIDATE BAYESIAN.. F-6 (MET) USING SIMULATED DATA TO VALIDATE BAYESIAN MIXED TREATMENT COMPARISON META-ANALYSIS FOR DIFFERENT EVIDENCE NETWORK PATTERNS AND NUMBERS OF STUDIES
Friday, October 19, 2012, Day Three
8:15 - 8:45 AM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B
Session Title PRES. PRESIDENTIAL ADDRESS - OPEN TO ALL ATTENDEES Click to view session
8:15 - 8:30 PRES-1 (INF) SMDM: IN QUEST OF QUALITY PRES-1 (INF) SMDM: IN QUEST OF QUALITY
8:45 - 9:45 AM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B
Session Title AWD1. SMDM LEADERSHIP AWARDS - OPEN TO ALL ATTENDEES Click to view session
8:45 - 9:05 AWD1-1 (DEC) SMDM CAREER ACHIEVEMENT AWARD AWD1-1 (DEC) SMDM CAREER ACHIEVEMENT AWARD
9:05 - 9:25 AWD1-2 (DEC) SMDM EUGENE L. SAENGER AWARD FOR DISTINGUISHED.. AWD1-2 (DEC) SMDM EUGENE L. SAENGER AWARD FOR DISTINGUISHED SERVICE
9:25 - 9:45 AWD1-3 (DEC) SMDM JOHN M. EISENBERG AWARD FOR PRACTICAL.. AWD1-3 (DEC) SMDM JOHN M. EISENBERG AWARD FOR PRACTICAL APPLICATION OF MEDICAL DECISION MAKING RESEARCH
10:00 - 11:30 AM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B
Session Title SYM2. INVITED SPEAKER SYMPOSIUM: BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND PUBLIC HEALTH DECISION MAKING Click to view session
10:00 - 10:01 SYM2-1 (HSP) BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND.. SYM2-1 (HSP) BIOMEDICAL INFORMATICS TO ENHANCE CLINICAL AND PUBLIC HEALTH DECISION MAKING
10:01 - 10:20 SYM2-2 (HSP) PUBLIC HEALTH INFORMATICS TO SUPPORT PUBLIC.. SYM2-2 (HSP) PUBLIC HEALTH INFORMATICS TO SUPPORT PUBLIC HEALTH DECISION MAKING
10:20 - 10:40 SYM2-3 (HSP) NATURAL LANGUAGE PROCESSING FOR AUTOMATIC.. SYM2-3 (HSP) NATURAL LANGUAGE PROCESSING FOR AUTOMATIC COHORT SELECTION
10:40 - 11:00 SYM2-4 (DEC) HARNESSING CLINICAL RESEARCH INFORMATICS TO.. SYM2-4 (DEC) HARNESSING CLINICAL RESEARCH INFORMATICS TO SUPPORT CLINICAL DECISION MAKING
11:00 - 11:20 SYM2-5 (HSP) LABORATORY TO PROMOTE/DEVELOP BETTER USABILITY.. SYM2-5 (HSP) LABORATORY TO PROMOTE/DEVELOP BETTER USABILITY OF CLINICAL SYSTEMS, INTERFACES, EFFECTIVENESS, AND INCORPORATION OF DECISION SUPPORT FOR IMPROVED CARE COORDINATION AND CONTINUITY
1:00 - 2:30 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B Regency Ballroom C Regency Ballroom D
Session Title G. RISK COMMUNICATION AND INDIVIDUAL DECISION MAKING EXPERIENCES Click to view session H. METHODS FOR COMPARATIVE EFFECTIVENESS RESEARCH Click to view session I. LUSTED FINALIST ABSTRACTS: QUANTITATIVE METHODS Click to view session
1:00 - 1:15 G-1 (DEC) BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN.. G-1 (DEC) BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK? H-1 (HSP) INFORMING CONSUMERS CHOICE OF HIGH QUALITY.. H-1 (HSP) INFORMING CONSUMERS CHOICE OF HIGH QUALITY FACILITIES FOR ELECTIVE SURGERY: COMPARING HEALTH PLAN CENTERS-OF-EXCELLENCE DESIGNATIONS WITH PUBLICLY REPORTED QUALITY METRICS I-1* (MET) ROBUSTNESS OF OPTIMAL MATCHING FOR USE IN.. I-1* (MET) ROBUSTNESS OF OPTIMAL MATCHING FOR USE IN EVIDENCE-BASED DECISION ALGORITHMS
1:15 - 1:30 G-2 (DEC) WHY DO I KNOW MORE ABOUT THE LOTTO THAN I DO.. G-2 (DEC) WHY DO I KNOW MORE ABOUT THE LOTTO THAN I DO ABOUT MY MEDICATIONS? NUMBERS MATTER TO INFORMED PATIENT CHOICES H-2 (HSP) META-ANALYSIS OF REAL-WORLD STUDIES OF.. H-2 (HSP) META-ANALYSIS OF REAL-WORLD STUDIES OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL/SYRINGE AMONG PATIENTS WITH TYPE 2 DIABETES: APPLYING A COMMON DATA STRUCTURE TO A UNIQUE EVIDENCE SYNTHESIS PLATFORM I-2* (MET) OPTIMIZING GUIDELINES FOR TIMING OF ARTERIOVEN.. I-2* (MET) OPTIMIZING GUIDELINES FOR TIMING OF ARTERIOVENOUS FISTULA CREATION IN CHRONIC KIDNEY DISEASE
1:30 - 1:45 G-3 (DEC) PARENTS' ATTITUDES ABOUT THE USE OF RESIDUAL.. G-3 (DEC) PARENTS' ATTITUDES ABOUT THE USE OF RESIDUAL NEWBORN BLOOD SPOTS FOR RESEARCH H-3 (HSP) A PNEUMONIA MORTALITY MODEL BASED ON HIGHLY.. H-3 (HSP) A PNEUMONIA MORTALITY MODEL BASED ON HIGHLY DETAILED ADMINISTRATIVE DATA I-3* (MET) FULLY ADAPTIVE DESIGNS FOR CLINICAL TRIALS:.. I-3* (MET) FULLY ADAPTIVE DESIGNS FOR CLINICAL TRIALS: SIMULTANEOUS LEARNING FROM MULTIPLE PATIENTS
1:45 - 2:00 G-4 (DEC) DOES KEEPING IT SIMPLE ACTUALLY HELP? TESTING.. G-4 (DEC) DOES KEEPING IT SIMPLE ACTUALLY HELP? TESTING THE IMPACT OF THE READING LEVEL OF A DECISION AID ON PROSTATE CANCER DECISION MAKING H-4 (HSP) WHY THE FINDINGS OF PUBLISHED BIOLOGIC.. H-4 (HSP) WHY THE FINDINGS OF PUBLISHED BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS MULTIPLE TREATMENT COMPARISON META-ANALYSES ARE DIFFERENT: AN OVERVIEW OF RECURRENT METHODOLOGICAL SHORTCOMINGS I-4* (MET) CALIBRATION METHODS FOR INFERRING TRANSITION.. I-4* (MET) CALIBRATION METHODS FOR INFERRING TRANSITION PROBABILITIES FROM CROSS-SECTIONAL STUDIES
2:00 - 2:15 G-5 (DEC) WOMEN'S PREFERENCES REGARDING PRENATAL TESTING.. G-5 (DEC) WOMEN'S PREFERENCES REGARDING PRENATAL TESTING FOR A RANGE OF GENETIC DISORDERS OF VARYING SEVERITY H-5 (AHE) AN INTEGRATED APPROACH TO EVALUATING.. H-5 (AHE) AN INTEGRATED APPROACH TO EVALUATING ALTERNATIVE RISK PREDICTION STRATEGIES: A CASE STUDY COMPARING ALTERNATIVE APPROACHES FOR PREVENTING INVASIVE FUNGAL DISEASE I-5* (MET) OPTIMAL SCREENING STRATEGIES OF PATIENTS ON.. I-5* (MET) OPTIMAL SCREENING STRATEGIES OF PATIENTS ON THE KIDNEY TRANSPLANT WAITING LIST
2:15 - 2:30 G-6 (DEC) DETERMINING THE RELATIONSHIP BETWEEN PATIENT.. G-6 (DEC) DETERMINING THE RELATIONSHIP BETWEEN PATIENT LITERACY AND THE DECISION MAKING EXPERIENCE OF PATIENTS WITH PROSTATE CANCER H-6 (HSP) BARIATRIC SURGERY: A SYSTEMATIC REVIEW AND.. H-6 (HSP) BARIATRIC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS, 2003-PRESENT I-6* (MET) OPTIMAL HEALTH PROGRAM INTERVENTION AND.. I-6* (MET) OPTIMAL HEALTH PROGRAM INTERVENTION AND INFORMATION ACQUISITION POLICY
4:00 - 5:30 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B Regency Ballroom C Regency Ballroom D
Session Title J. VALUES, PREFERENCE ELICITATION AND UTILITY ASSESSMENT Click to view session K. COST-EFFECTIVENESS ANALYSIS: IMPLICATIONS FOR PREVENTION AND TREATMENT OF DISEASE Click to view session L. LUSTED FINALIST ABSTRACTS D: HEALTH SERVICES & POLICY RESEARCH Click to view session
4:00 - 4:15 J-1 (DEC) BRIEF EDUCATION AND COMPLETING A CONJOINT.. J-1 (DEC) BRIEF EDUCATION AND COMPLETING A CONJOINT VALUATION SURVEY REDUCE DECISIONAL CONFLICT REGARDING LUNG CANCER SCREENING AMONG INDIVIDUALS AT-RISK FOR LUNG CANCER K-1 (AHE) THE COST-EFFECTIVENESS OF INTEGRATED CERVICAL.. K-1 (AHE) THE COST-EFFECTIVENESS OF INTEGRATED CERVICAL CANCER PREVENTION STRATEGIES IN THE ONTARIO SETTING – CAN WE DO BETTER? L-1* (HSP) COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENE.. L-1* (HSP) COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIRETROVIRAL THERAPY AND PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION IN SOUTH AFRICA
4:15 - 4:30 J-2 (DEC) HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND.. J-2 (DEC) HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND FIT BETWEEN VALUES AND OPTIONS HELPS PEOPLE MAKE CHOICES CONCORDANT WITH THEIR STATED VALUES K-2 (AHE) CERVICAL CANCER SCREENING AND HUMAN PAPILLOMAV.. K-2 (AHE) CERVICAL CANCER SCREENING AND HUMAN PAPILLOMAVIRUS VACCINATION IN ITALY: A COST-EFFECTIVENESS ANALYSIS L-2* (HSP) DYNAMIC TRANSMISSION MICROSIMULATION OF.. L-2* (HSP) DYNAMIC TRANSMISSION MICROSIMULATION OF TUBERCULOSIS IN INDIA TO ASSESS THE FUTURE IMPACT OF TREATMENT PROGRAMS
4:30 - 4:45 J-3 (DEC) INFORMING ADVANCE DIRECTIVES BY EXPLICITLY.. J-3 (DEC) INFORMING ADVANCE DIRECTIVES BY EXPLICITLY SIMULATING CARE TRAJECTORIES K-3 (DEC) IS REFUSAL TO TAKE FRACTURE PREVENTION.. K-3 (DEC) IS REFUSAL TO TAKE FRACTURE PREVENTION MEDICATION SOMETIMES A RATIONAL DECISION? AN EXPLORATORY ANALYSIS THROUGH THE LENS OF COST-EFFECTIVENESS L-3* (HSP) COMPARING FIFTEEN APPROACHES OF ASSESSING.. L-3* (HSP) COMPARING FIFTEEN APPROACHES OF ASSESSING CARDIOVASCULAR DISEASE RISK USING RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS
4:45 - 5:00 J-4 (DEC) MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING.. J-4 (DEC) MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING DIRECT HEALTH UTILITY ASSESSMENT K-4 (AHE) MULTIFACTORIAL DECISION MAKING FOR CHEMOTHRAPY.. K-4 (AHE) MULTIFACTORIAL DECISION MAKING FOR CHEMOTHRAPY IN EARLY-STAGE BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF ONCOTYPE DX L-4* (HSP) THE WELFARE CONSEQUENCES OF THE DONOR PRIORITY.. L-4* (HSP) THE WELFARE CONSEQUENCES OF THE DONOR PRIORITY RULE
5:00 - 5:15 J-5 (DEC) WHAT FACTORS EXPLAIN WILLINGNESS TO TRADE TIME.. J-5 (DEC) WHAT FACTORS EXPLAIN WILLINGNESS TO TRADE TIME IN THE TIME TRADE-OFF EXERCISES, AND WHAT FACTORS ARE IMPORTANT? K-5 (AHE) COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC.. K-5 (AHE) COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC TESTING TO INFORM INITIAL ANTIRETROVIRAL PRESCRIBING FOR TREATMENT OF HIV IN THE US L-5* (HSP) COST-EFFECTIVENESS OF SCREENING RESISTANT.. L-5* (HSP) COST-EFFECTIVENESS OF SCREENING RESISTANT HYPERTENSIVE PATIENTS FOR PRIMARY ALDOSTERONISM
5:15 - 5:30 J-6 (DEC) ANXIETY AND ACTION BIAS AS PREDICTORS OF.. J-6 (DEC) ANXIETY AND ACTION BIAS AS PREDICTORS OF PROSTATE CANCER TREATMENT PREFERENCES AND TREATMENT DECISIONS K-6 (HSP) COST-EFFECTIVENESS OF METAL-ON-METAL HIP.. K-6 (HSP) COST-EFFECTIVENESS OF METAL-ON-METAL HIP RESURFACING COMPARED TO CONVENTIONAL TOTAL HIP ARTHROPLASTY L-6* (HSP) COST-EFFECTIVENESS OF BLOOD DONOR SCREENING.. L-6* (HSP) COST-EFFECTIVENESS OF BLOOD DONOR SCREENING FOR BABESIOSIS IN ENDEMIC REGIONS
5:30 - 6:15 PM
Attendees are invited to move from room-to-room
Room Regency Ballroom A/B
Session Title AWD2. SMDM EARLY CAREER AWARDS - OPEN TO ALL ATTENDEES Click to view session
5:30 - 5:45 AWD2-1 (DEC) EUROPEAN 2012 MEETING AWARD FOR OUTSTANDING.. AWD2-1 (DEC) EUROPEAN 2012 MEETING AWARD FOR OUTSTANDING PAPER BY A YOUNG INVESTIGATOR
5:45 - 6:00 AWD2-2 (DEC) US 2012 AWARD FOR OUTSTANDING PAPER BY A YOUNG.. AWD2-2 (DEC) US 2012 AWARD FOR OUTSTANDING PAPER BY A YOUNG INVESTIGATOR
6:00 - 6:15 AWD2-3 (DEC) SMDM LEE B. LUSTED STUDENT PRIZE AWARD AWD2-3 (DEC) SMDM LEE B. LUSTED STUDENT PRIZE AWARD